Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Early Serum Free Light Chain Responses Following High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis.

Saulius Girnius, MD, Frank Tsai, MD, David C. Seldin, MD, PhD, Karen Quillen, MD, Lisa Yanarella, NP, Kathleen T. Finn, NP, Nancy T. Andrea, MD, John Mark Sloan, MD, Martha Skinner, MD, Vaishali Sanchorawala, MD

Blood (2009) 114 (22): 4352.

https://doi.org/10.1182/blood.V114.22.4352.4352

Published: 2009

Journal Articles

Bortezomib and High Dose Melphalan Followed by Autologous Stem Cell Transplantation (BortHDM/SCT) for the Treatment of AL Amyloidosis: Results of a Feasibility Study.

Vaishali Sanchorawala, MD, Lisa Yanarella, NP, Karen Quillen, MD, John Mark Sloan, MD, Nancy T. Andrea, MD, Kathleen T. Finn, NP, David C. Seldin, MD, PhD

Blood (2009) 114 (22): 4353.

https://doi.org/10.1182/blood.V114.22.4353.4353

Published: 2009

Journal Articles

Long Term Results of High-Dose Melphalan and Autologous Stem Cell Transplantation in Non-Amyloid Monoclonal Immunoglobulin Deposition Disorders.

Saulius Girnius, MD, David C. Seldin, MD, PhD, Karen Quillen, MD, Kathleen T. Finn, NP, Nancy T. Andrea, MD, John Mark Sloan, MD, Vaishali Sanchorawala, MD

Blood (2009) 114 (22): 4356.

https://doi.org/10.1182/blood.V114.22.4356.4356

Published: 2009

Journal Articles

Melphalan, Lenalidomide, and Dexamethasone Combination Therapy in Patients with AL Amyloidosis.

John Mark Sloan, MD, Vaishali Sanchorawala, MD, Saulius Girnius, M.D., Kathleen T. Finn, NP, David C. Seldin, MD, PhD

Blood (2009) 114 (22): 1859.

https://doi.org/10.1182/blood.V114.22.1859.1859

Published: 2009

Journal Articles

Hepatic Response after High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis Associated Liver Disease.

Saulius Girnius, MD, David C. Seldin, MD, PhD, Martha Skinner, MD, Kathleen T. Finn, NP, Vaishali Sanchorawala, MD

Blood (2007) 110 (11): 2873.

https://doi.org/10.1182/blood.V110.11.2873.2873

Published: 2007

NARROW

Early Serum Free Light Chain Responses Following High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis.

Bortezomib and High Dose Melphalan Followed by Autologous Stem Cell Transplantation (BortHDM/SCT) for the Treatment of AL Amyloidosis: Results of a Feasibility Study.

Long Term Results of High-Dose Melphalan and Autologous Stem Cell Transplantation in Non-Amyloid Monoclonal Immunoglobulin Deposition Disorders.

Melphalan, Lenalidomide, and Dexamethasone Combination Therapy in Patients with AL Amyloidosis.

Hepatic Response after High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis Associated Liver Disease.

Email alerts

ASH Publications

American Society of Hematology

Early Serum Free Light Chain Responses Following High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis.

Bortezomib and High Dose Melphalan Followed by Autologous Stem Cell Transplantation (BortHDM/SCT) for the Treatment of AL Amyloidosis: Results of a Feasibility Study.

Long Term Results of High-Dose Melphalan and Autologous Stem Cell Transplantation in Non-Amyloid Monoclonal Immunoglobulin Deposition Disorders.

Melphalan, Lenalidomide, and Dexamethasone Combination Therapy in Patients with AL Amyloidosis.

Hepatic Response after High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis Associated Liver Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only